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OBJECTIVE: It is essential to identify a serological marker of injury in order to study the pathophysiology of
intestinal ischemia reperfusion. In this work, we studied the evolution of several serological markers after
intestinal ischemia reperfusion injury in rats. The markers of non-specific cell damage were aspartate
aminotransferase, alanine aminotransaminase, and lactic dehydrogenase, the markers of inflammation were
tumor necrosis factor alpha, interleukin-6, and interleukin-1 beta, and the markers of intestinal mucosal
damage were intestinal fatty acid binding protein and D-lactate. We used Chius classification to grade the
histopathological damage.
METHODS: We studied 35 Wistar rats divided into groups according to reperfusion time. The superior
mesenteric artery was clamped for 30 minutes, and blood and biopsies were collected at 1, 3, 6, 12, 24, and
48 hours after reperfusion. We plotted the mean ¡ standard deviation and compared the baseline and
maximum values for each marker using Student’s t-test.
RESULTS: The maximum values of interleukin-1 beta and lactic dehydrogenase were present before the
maximal histopathological damage. The maximum tumor necrosis factor alpha and D-lactate expressions
coincided with histopathological damage. Alanine aminotransaminase and aspartate aminotransferase had a
maximum expression level that increased following the histopathological damage. The maximum expressions
of interluken-6 and intestinal fatty acid binding protein were not significantly different from the Sham treated
group.
CONCLUSION: For the evaluation of injury secondary to acute intestinal ischemia reperfusion with a 30 minute
ischemia period, we recommend performing histopathological grading, quantification of D-lactate, which is
synthesized by intestinal bacteria and is considered an indicator of mucosal injury, and quantification of tumor
necrosis factor alpha as indicators of acute inflammation three hours after reperfusion.
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& INTRODUCTION
Intestinal ischemia reperfusion (IR), or transient hypoxia
followed by re-oxygenation, is a component of the
pathogenesis of all diseases that involve a reduction or
redistribution of bowel blood flow, including shock,
neonatal necrotizing enterocolitis, intestinal transplant,
and mesenteric ischemia. As such, IR can complicate
surgical procedures in the elderly and for open-heart
surgery patients (1–3). In clinical practice, symptoms
are often vague, making a definitive diagnosis of
acute intestinal ischemia notoriously difficult (4). When
accompanied by clinical signs of peritonitis, this
usually indicates necrosis of the intestinal wall, and the
suspicion of intestinal ischemia is traditionally confirmed
by laparotomy (5).
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In humans, the systematic search for serological markers
of intestinal ischemia to optimize early diagnosis has
identified molecules such as D-lactate (6), glutathione S-
transferase (GST) (7), and intestinal fatty acid binding
protein (iFABP) (8,9). However, a combination of markers,
or a ‘‘diagnostic intestinal ischemia panel,’’ reflecting
different aspects of bowel viability has not been identified
(10). The temporal association between IR and serum
markers is also not well understood. The identification of
a set of serum markers (SM) that could detect or predict the
outcome of an ischemic insult would be essential for
studying the pathophysiology of IR.
Numerous publications have reported the effects of drugs
and therapeutic modalities on IR injury based on histologi-
cal damage (11,12) and alterations of serum levels of
molecules that are associated with cell damage, endothelial
activation, inflammation, and oxidative stress (13–15).
However, the evaluation times are often fixed or arbitrary,
and the temporal dynamics of histological and serological
injury markers remain obscure. Nonetheless, in most
studies of experimental IR, histopathological examination
is the gold standard. In 1970, Chiu reported a graded scale
of damage produced by ischemia in the intestinal mucosa
based on hematoxylin and eosin staining (12). Later, Parks
and Sonnino reported scores, and Park reported a modifica-
tion to the original Chiu score (16). The Chiu and Chiu/
Parks classifications are currently recommended for com-
paring results reported in the literature (11,17).
In this article, we were interested in identifying combina-
tions of serum and histopathological studies at different
time points. Therefore, we assessed the evolution of
histopathological injury and serum markers of non-specific
cell damage: aspartate aminotransferase (AST), alanine
aminotransaminase (ALT), and lactic dehydrogenase
(LDH), of acute inflammation: tumor necrosis factor alpha
(TNF-alpha), interleukin 6 (IL-6), and interleukin-1 beta (IL-
1), and of intestinal mucosa damage: intestinal fatty acid
binding protein (iFABP) and D-lactate during reperfusion.
& MATERIAL AND METHODS
Animals procedures
The animal procedures were performed in accordance
with the proper use and care of laboratory animals. The
experiments were performed on 35 female Wistar rats
weighing 200–250 g. The animals were maintained under
standard conditions, including stable room temperature, a
12:12-h light/dark cycle, and access to commercial rat
pellets and water ad libitum. The ethics committee of our
institution approved this study.
Animal model
In brief, after 12 hours of fasting and anesthesia with a
40 mg/kg intraperitoneal injection (IP) of pentobarbital
sodium (Anestesal; Pfizer, Mexico City, Mexico), a midline
laparotomy was performed, and ischemia was induced by
occlusion of the superior mesenteric artery with vascular
clamps. An absent pulse was visually verified in the
mesenteric vessels with a brown discoloration of the
intestine. After 30 minutes of ischemia, blood flow was
restored, and the abdominal wall was sutured.
The animals were divided into 7 groups (n = 5) and were
named according to the reperfusion time: Sham group or
negative control, which underwent surgery without arterial
occlusion, and groups with 1 hour, 3 hours, 6 hours,
12 hours, 24 hours, and 48 hours of reperfusion.
Depending on the group, at the end of the reperfusion
time, the rats were anesthetized, the sutures were removed,
blood samples were obtained from the aorta, and full-bowel
wall samples of the ileum, 15 cm from the ileocecal junction,
were obtained. The animals were then euthanized by
exsanguination.
Morphological examination
Intestinal biopsies were fixed in 10% formalin, processed
with conventional histological techniques, and stained with
hematoxylin and eosin. To assess mucosal injury, the Chiu
classification was used (6). The evaluation scale was from 0
to 5, where 0 is a normal intestinal mucosa, 1 is the
development of Gruenhagen subepithelial spaces, 2 is the
extension of the subepithelial space with moderate lifting of
the lamina propria, 3 is the expansion of epithelial lifting
with destruction of the tips of villi, 4 is destroyed villi with
exposure of the lamina propria and dilated capillaries, and 5
is the disintegration of the lamina propria, hemorrhage, and
ulceration.
Serum determinations
After exsanguinating the animal, at least 3 mL of blood
was collected and allowed to clot, and the serum was
separated by centrifugation and stored at 270 C˚ until
further study.
The serum levels of TNF-alpha were determined using a
Rat TNF-alpha enzyme-linked immunosorbent assay
(ELISA) kit (Peprotech, Rocky Hill, NJ, USA). Serum levels
of IL-1 were determined using a Rat IL-1 beta ELISA kit
(Peprotech). Serum levels of IL-6 were determined using a
Rat IL-6 ELISA kit (Peprotech). The serum levels of iFABP
were determined using a Rat iFABP ELISA kit (Biotang,
Waltham, MA, USA). The serum levels of D-lactate were
determined using a EnzyChromTM D-Lactate Assay Kit
(BioAssay Sytems, Hayward, CA, USA).
The serum levels of AST, ALT and LDH activity were
determined by reflectance on a Vitros DT60II System Ortho
Clinical Diagnostics by Johnson & Johnson (Rochester, New
York, USA).
Statistical analysis
Using SPSS V15 software, we plotted the time variations
in the parameters studied, identified the peaks (Pmax) for
each parameter and compared them against the baseline
(Sham) with t tests for two independent samples. A value of
p,0.05 was considered to be statistically significant.
& RESULTS
Histopathological changes
The histomorphological damage to the intestinal epithe-
lium according to the Chiu scale was evident in our model
at one hour, was maximal at three hours, and returned to
baseline levels after 12 hours of reperfusion. The damage
was undetectable at 24 and 48 hours (Figure 1).
Non-specific markers of cell damage
Of the non-specific markers of cell damage, LDH peaked
at one hour of reperfusion, AST peaked at 6 hours and ALT
peaked at 12 hours. The latter two showed a significant
elevation at 3 hours (Figure 1).
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TNF-alpha, IL-1beta, IL-6, iFABP and D-lactate
The markers whose levels coincided with the peak of
injury (Pmax) were TNF-alpha and IL-1beta, which peaked
at one hour and remained elevated until 3 hours. No
differences were observed at 6 hours compared to the
control group. Serum D-lactate did not decrease after
reaching its maximum at 3 hours (Figure 1). The levels of
IL-6 peaked at 12 hours of reperfusion but did not differ
from the controls. The iFABP concentration did not
significantly differ from the controls at any time.
Significant differences were documented between the
sham group and Pmax in injury scores, non-specific injury
markers (LDH, AST and ALT), the inflammatory markers
TNF-alpha and IL-1beta, and the specific injury marker D-
lactate. There were no significant differences in the
concentrations of iFABP or IL-6 (Table 1).
& DISCUSSION
The intestinal mucosa is particularly sensitive to IR injury.
We observed severe mucosal injury beginning at 1 hour of
perfusion, reaching maximal severity at 3 hours and
subsiding at 24 hours. This is consistent with other reports
that morphological intestinal repair begins shortly after
3 hours of reperfusion and is complete around 24 hours
(18–20). During reperfusion, the cascade of events that seeks
to limit damage and maintain homeostasis involves all the
components of the digestive tract: mucous cells, fibroblasts,
neurons, endothelial cells and the immune system (21).
Previous studies have correlated the duration of ischemia
with histological damage to the intestinal mucosa (22). At 30
minutes of ischemia, cellular reserves of oxygen are
consumed (12), and the mucosa loses its ability to
accumulate sugars and amino acids against a concentration
gradient (23). Histological lesions secondary to ischemia are
exacerbated by reperfusion. The period of time of ischemia,
the type of ischemia (arterial, venous, arterial and venous)
(24), and the time to reperfusion all determine the severity
of injury.
The concentrations of LDH and IL-1 increased before the
lesion was identified histopathologically. LDH is a non-
specific marker of cell injury and has been associated with
ischemic events in the intestine (25), while interleukin-1 beta
is considered a marker of acute inflammation, resulting in
the activation of macrophages during early stages of tissue
injury. Serum levels of LDH, but not IL-1beta, have been
shown to remain elevated 72 hours after intestinal IR in rats
(26). Peak serum concentrations of D-lactate and TNF-alpha
coincided with histopathological injury. TNF-alpha, in
concordance with previous reports (24), increased upon
injury. Both TNF and IL-1 are essential in the physiopathol-
ogy of IR and are widely used in studies evaluating
intestinal IR injury (27). Additionally, the intestine has been
identified as a source of TNF during IR-mediated damage
(28). However, these are non-specific markers of inflamma-
tion and systemic injury, which makes their diagnostic
utility questionable.
Intestinal gut barrier dysfunction is an important aspect
of the physiopathology of IR injury. Intestinal bacteria
produce D-lactate, and its presence in serum reflects a
major failure of the mucosal barrier (25). In a systematic
literature review of clinical studies, D-lactate was indeed
found to be one of the most well studied and reliable
biomarkers of intestinal ischemia (10). However, in a rat
Figure 1 - Temporal evolution of serum marker levels and
histological damage at different times of reperfusion. Chiu:
histopathological damage scored according to Chiu, LDH: lactic
dehydrogenase, IL-1: interleukin-1 beta, AST: aspartate amino-
transferase, ALT: alanine aminotransaminase, TNF-a: tumor
necrosis factor alpha. *p,0.05 versus Sham.
Serum Markers During Intestinal Ischemia
Guzma´n-de la Garza FJ et al.
CLINICS 2013;68(7):1034-1038
1036
model of gut IR induced by aortic clamping, D-lactate was
not elevated in the serum after 1 hour of reperfusion
following 40 minutes of ischemia, consistent with our
results (29). We did find that D-lactate was elevated at
3 hours, which coincided with severe mucosal injury and,
presumably, gut barrier dysfunction. This suggests that D-
lactate sensitivity is time-dependent and correlates to
structural mucosal injury.
Interestingly, D-lactate remained elevated at 48 hours.
This could indicate prolonged functional impairment and
bacterial translocation independent of mucosal morpholo-
gical integrity. Support for this idea comes from previous
studies that showed elevated D-lactate at 48 hours of
reperfusion and correlated to bacteremia following 1 hour
of intestinal ischemia in rats (30). Human studies have
confirmed persistent elevations of D-lactate 48 hours after
reperfusion during colonic ischemia (31). The temporal
dynamics of tight-junction alterations in the intestinal
mucosa, thought to be a basis for barrier dysfunction after
IR (32), could partly explain this result. Additionally,
experimental studies in primates have shown that serum
D-lactate levels can predict mortality in models of hemor-
rhagic shock (33). This adds to the possible clinical value of
D-lactate as a biomarker in settings of intestinal IR.
Another specific mucosal injury marker, iFABP (25), was
unrelated to histopathology during the acute phase in our
study. Rat models of acute intestinal IR have shown
elevations of iFABP early in the course of intestinal mucosal
injury (34). Clinical studies have documented an elevation
of iFABP as a specific marker for mucosal injury. Although
the source of iFABP is assumed to be the cells of the
intestinal mucosa, its utility is based on the identification of
a chronic process of local lesions (8,9,25). However, recent
clinical studies have found elevations of iFABP during
acute intestinal necrosis (35). Not all studies have been
consistent: iFABP was not correlated to intestinal IR at any
time point (1, 3 and 6 hours reperfusion) in a recent study
in rabbits (36). Together with our results, this suggests that
the role of iFABP as a biomarker for intestinal ischemia
remains unclear.
We identified ALT and AST as molecules that remained
elevated even after histopathological injury had subsided,
peaking at 6 and 24 hours post-ischemia. A previous study
showed that AST and LDH elevations occurred early after
IR, but no ALT elevations were evident at 120 minutes of
reperfusion (37). This suggested that the origin of AST and
LDH was indeed the intestine and not the liver. In our
study, we also found delayed ALT elevations. During
reperfusion, peripheral organs, such as the lung and liver,
displayed injury as a result of polymorphonuclear leukocyte
infiltration and the release of inflammatory mediators into
the bloodstream (38). Liver and lung injury indeed occur
after intestinal IR, and the elevation of these enzymes
appears to reflect remote organ damage (39).
The use of fixed time models of intestinal IR injury using
serum markers as surrogates for histopathological analysis
should be discouraged. Both serum markers and histology
are important in grading the severity of IR injury.
Additionally, the chosen markers should ideally coincide
with mucosal injury. Studying the changes in concentration
of these markers during experimentation will allow for a
better understanding of the process. When planning a study
on IR injury, it is essential to identify the times at which
measurements will be carried out, as this could reflect
different aspects of the physiopathology.
Our study has several limitations. We only used one
ischemia time (30 minutes), making it impossible to directly
establish correlations between the serum markers and local
or systemic injury. We used a sublethal model of intestinal
IR and could not make associations with mortality. We did
not directly measure for mucosal barrier permeability, and
we did not carry out immunohistochemical or ultrastruc-
tural investigations of the injured mucosa. These are areas of
future research.
In conclusion, AST, LDH, IL-1 and TNF-alpha are
elevated early after reperfusion, and in the case of TNF-
alpha, correlate well with maximal mucosal injury.
However, they are non-specific markers of tissue injury
(AST, LDH) or part of the systemic inflammatory response
(IL-1, TNF-alpha). Their utility as diagnostic tools is thus
limited, but they could reflect injury severity. We were
surprised not to find changes in IL-6 levels considering the
evidence of its involvement in IR injury (26–40). D-lactate is
a more promising clinical biomarker of intestinal injury and
could be used to evaluate functional (barrier) alterations. It
coincided with maximal injury in our study and remained
elevated after 48 hours. However, D-lactate was not
elevated in the hyperacute phase of intestinal ischemia
(1 hour of reperfusion). The specific roles of other markers,
such as iFABP, coagulation parameters (41), oxidative stress
(42), and adhesion molecules (40), requires further investi-
gation.
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